2025 ICD-10-CM code C80.2
(Active) Effective Date: N/A Neoplasms - Malignant neoplasm without specification of site 2 Feed
Malignant neoplasm associated with transplanted organ. This code is used to indicate a cancerous growth in a transplanted organ.
Medical necessity must be established by demonstrating that the malignancy is related to the transplanted organ or the immunosuppressive therapy used post-transplant. Documentation should clearly link the cancer to the transplant. This could include evidence of immunosuppression, time of onset of the malignancy, or any other clinical findings supporting the association.
The provider is responsible for diagnosing and managing the malignancy, which includes determining the type and stage of the cancer, developing a treatment plan (which may involve surgery, chemotherapy, and/or radiation therapy), monitoring the patient's response to treatment, and managing any complications. The provider should also educate the patient about their condition and treatment options.
In simple words: This code signifies cancer in a transplanted organ. It's used when cancer develops after the organ transplant, and is distinct from cancer that existed before or came with the donated organ.
Malignant neoplasm associated with transplanted organ. This refers to cancerous growth of cells in an organ that has been transplanted.It's important to distinguish this from a pre-existing malignancy in the recipient or a cancer that originated in the donor organ prior to transplant. This code should be used in conjunction with codes specifying the type of malignancy and any complications related to the transplant.
Example 1: A patient who received a kidney transplant five years ago presents with abdominal pain and weight loss. Imaging reveals a mass in the transplanted kidney, which is subsequently biopsied and diagnosed as renal cell carcinoma. The codes T86.19, Other complications of kidney transplant, C80.2, Malignant neoplasm associated with transplanted organ, and C64.9, Malignant neoplasm of kidney, unspecified would be reported., A patient who underwent a heart transplant develops lymphoma two years post-transplant. This lymphoma is determined to be related to the immunosuppressive therapy the patient received. Codes T86.89, Other complications of heart transplant, C80.2, and C85.9, Malignant lymphoma, unspecified would be assigned., A liver transplant recipient develops skin cancer (specifically, basal cell carcinoma) on their arm three years post-transplant. Since this skin cancer isn't directly related to the transplanted organ, only C44.9 and a code from category T86.4, Complications of liver transplant, if relevant, would be used. C80.2 is not appropriate in this case.
Documentation should include details regarding the transplanted organ, the date of transplant, the type and location of the malignancy, confirmation of the malignancy via diagnostic testing (such as biopsy), and the relationship of the malignancy to the transplant. Any complications arising from the malignancy or its treatment should also be documented.
** It's crucial to accurately document the timeline of events to differentiate between malignancies associated with the transplanted organ itself and those related to other factors like pre-existing conditions or immunosuppressive therapy. For malignancies arising in non-transplanted sites in transplant recipients, C80.2 would not be applicable.
- Payment Status: Active
- Specialties:Oncology, Transplant Surgery, and the specialty related to the transplanted organ (e.g., Nephrology for kidney transplant, Cardiology for heart transplant).
- Place of Service:Inpatient Hospital, Outpatient Hospital, Physician's Office